PHVS- Pharvaris N.V.

Name: Pharvaris N.V. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Pharvaris N.V. (PHVS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. PHVS is classified in the Biotechnology industry within the Healthcare sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Schikan Johannes Gerardus Christiaan Petrus	355.2K	$11.65M	-
Other	Lu Peng	219.5K	$7.20M	-
CEO	Modig Berndt	135.2K	$4.43M	-2,291
Other	Lesage Anne	56.5K	$1.85M	-
Other	Nijdam Anna	46.3K	$1.52M	-2,670

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 15, 2026	Modig Berndt	Chief Executive Officer	Sell	2,291	$31.07	$71,173.04	-0.8%	-	-
Jun 4, 2026	Nijdam Anna	Principal Accounting Officer	Sell	2,670	$30.87	$82,425.04	-5.5%	-	-
May 20, 2026	Bjork Elisabeth	Director	Sale+OE	10,000	$29.32	$293,166.00	-39.7%	-	-
Apr 30, 2026	Lu Peng	Chief Medical Officer	Sale+OE	18,733	$30.21	$565,859.27	-12.7%	-	-
Apr 30, 2026	Schikan Johannes Gerardus Christiaan Petrus	Director	Sell	32,900	$30.29	$996,544.70	-2.9%	-	-
Apr 30, 2026	Lesage Anne	Chief Early Development	Sale+OE	48,300	$30.23	$1,459,970.16	-9.6%	-	-
Apr 23, 2026	Lu Peng	Chief Medical Officer	Sale+OE	7,101	$30.05	$213,404.75	-5.1%	-	-
Apr 23, 2026	Lesage Anne	Chief Early Development	Sale+OE	14,700	$30.05	$441,725.60	-3.0%	-	-
Apr 16, 2026	Modig Berndt	Chief Executive Officer	Sell	2,292	$28.60	$65,558.53	-1.6%	-	-
Apr 9, 2026	Modig Berndt	Chief Executive Officer	Sell	23,333	$27.74	$647,281.38	-7.6%	-	-

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC